Andrea Ossato

11PUBLICATIONS
15CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Disease surveillanceApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Regenerative medicine (incl. stem cells)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 15, 2026
Long-term outcomes of ALK inhibitors in metastatic ALK-positive non-small cell lung cancer: an updated indirect comparison using reconstructed patient-level data.

|Nov 27, 2025
Comparative Analysis of Maintenance Treatments in Patients with Newly Diagnosed Advanced Ovarian Cancer After First-Line Platinum-Based Regimens.

Lorenzo Gasperoni, Luca Cancanelli, Andrea Ossato

|Jan 24, 2025
Treatment Options for Advanced Non-Small Cell Lung Cancer After Failure of Previous Immune Checkpoint Inhibitors and Chemotherapy: Meta-Analysis of Five Randomized Controlled Trials.

Andrea Messori, Andrea Ossato, Lorenzo Gasperoni

|Nov 19, 2024
Rapid Desensitization to Antitumoral Agents. Result from a Retrospective Study, DESARCh.

Roberto Tessari, Andrea Ossato, Francesca Realdon

|Oct 21, 2024
Comparative efficacy of chemo-immunotherapy combination regimens in the frontline setting for NSCLC based on reconstructed patient data.

Andrea Ossato, Luna Del Bono, Lorenzo Gasperoni

|Jul 13, 2024
A Head-to-Head Comparison of the First-Line Treatments for Locally Advanced or Metastatic Urothelial Cancer: Is There Still a Role for Chemotherapy?

Lorenzo Gasperoni, Luna Del Bono, Andrea Ossato

Pageof 2

Frequent Collaborators

6 joint publications

Andrea Messori

5 joint publications

Lorenzo Gasperoni

3 joint publications

Roberto Tessari

2 joint publications

Luca Cancanelli